Abstracts
Introduction:
There is a paucity of data regarding the presentation, management and the long-term outcomes of very elderly patients who suffer from a type II myocardial infarction.
Methods: A single-centre retrospective analysis of 956 consecutive patients aged >85 years presenting with NSTEMI between 2010-2018 was undertaken. Patients were stratified by type I vs Type II MI as defined by the 4 th Universal Definition of MI. The primary outcome was all-cause longterm mortality ascertained by review of electronic medical records.
Results: Mean age of the cohort was 89 ± 3 years and 43.8% were male. Of the 956 patients included, 477 (50%) suffered a type II MI. The predominant presentations of patients presenting with type II MI included delirium (34.3%), sepsis (18.4%), non-cardiac surgery (8.5%) and bleeding/anaemia (6.7%). Those with Type II MI were less likely to undergo invasive coronary angiography (2.5 vs 17.0%, p < 0.001) and less likely to be prescribed aspirin (77 vs 84%) although rates of statin use were higher (78 vs 69%, p < 0.001). In-hospital mortality was significantly higher in those with type II MI (21.1 vs 13.5%, p = 0.002). Over a mean follow-up of 1.3 years, 444 patients died (46.4%). Despite higher in-hospital mortality, on multivariable Cox-regression, Type II MI was not significantly associated with higher long-term mortality (adjusted HR 1.1 95%CI 0.8-1.2, p = ns).
Conclusion: Type II MI is common in elderly patients and confers a high risk of in-hospital mortality. At present, there is a lack of evidence to risk stratify and guide treatment in this population. Background: There have been mixed outcomes for women undergoing Percutaneous Coronary Intervention (PCI). Studies in selected cohorts such as acute coronary syndromes (ACS) have shown poor early outcomes, while other earlier studies showed female gender to be protective for short to medium term (1 year) outcomes. Utilising clinical quality registry data in the contemporary era of PCI, we sought to evaluate the longer-term mortality for women.
Methods: From 2013 to 2017, consecutive patients undergoing PCI from across Victoria were prospectively entered into the Victorian Cardiac Outcomes Registry. The primary endpoint was longer-term mortality (mean+/-SD, 720.6 +/-444.9 days) via linkage to the National Death Index. Multivariate logistic regression was used to analyse independent predictors of longer-term mortality.
Results: A total of 36,448 patients (23.5% female) underwent PCI, of whom 33.4% presented with stable coronary artery disease and 66.6% with ACS (ST elevation MI 24.2%, non-STEMI 31.4%, unstable angina 11.1%). Females were on average 4.7 years older than males (68.8 vs. 64.1, p < 0.001), had more comorbidities such as diabetes (25.9% vs. 22.9%) and cerebrovascular disease (28.3% vs. 23.4%), p < 0.001 for both. Predictors of longer-term mortality were previous PCI (HR 1.04, p < 0.01) and severe renal impairment (HR 1.22, p < 0.001). Presentation type and ejection fraction were not predictors of longer-term mortality. Female gender was independently associated with increased longer-term mortality (HR 1.04, p = 0.03).
Conclusions: In this large state wide registry, female gender was associated with an increased likelihood of longer-term mortality. 
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Background: Many outer-metropolitan and rural hospitals rely on thrombolysis to manage patients with ST-elevation myocardial infarction (STEMI) due to patients being 90 minutes away from percutaneous coronary intervention (PCI)
